No Data
No Data
Express News | HC Wainwright & Co. Reiterates Buy on Sangamo Therapeutics, Maintains $10 Price Target
J.M. Smucker Posts Upbeat Earnings, Joins LexinFintech, Semtech, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
Analyst Forecasts For Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Are Surging Higher
Sangamo Stock Climbs 12% Post-market on FDA Update for ST-503
Sangamo Therapeutics Gets FDA Clearance for Investigational NDA for Pain Treatment
Sangamo Therapeutics Gets FDA Clearance Of IND Application For ST-503 For Treatment Of Idiopathic Small Fiber Neuropathy
No Data